30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cheng Sohanya Roshan

Insider profile

Performance

Overall performance
3.8

Performance over holding periods
3.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Cheng Sohanya Roshan's trades of Karyopharm Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-15 2026-05-14 S Sale
28,814 +48.3%
228.41
US$4,490,847
28,814 +48.3% 228.41 US$4,490,847
2026-03-03 2026-03-02 S Sale
66,193 -11.2%
340.57
US$4,531,690
66,193 -11.2% 340.57 US$4,531,690
2025-09-16 2025-09-15 S Sale
30,537 -49.7%
329.80
US$3,023,417
30,537 -49.7% 329.80 US$3,023,417
2025-03-06 2025-03-04 S Sale
3,445 -9.1%
6.29
US$21,669
3,445 -9.1% 6.29 US$21,669
2024-09-05 2024-09-04 PlS Planned sale
5,356 -1.3%
0.72
US$3,866
5,356 -1.3% 0.72 US$3,866
2024-03-04 2024-03-01 S Sale
5,109 -1.3%
1.20
US$6,131
5,109 -1.3% 1.20 US$6,131
2024-03-04 2024-02-29 S Sale
21,840 -5.2%
1.17
US$25,553
21,840 -5.2% 1.17 US$25,553
2023-09-05 2023-09-01 S Sale
7,415 -3.5%
1.33
US$9,872
7,415 -3.5% 1.33 US$9,872
2023-06-12 2023-06-08 PlS Planned sale
1,839 -0.9%
2.35
US$4,322
1,839 -0.9% 2.35 US$4,322
2023-03-02 2023-03-01 S Sale
11,239 -5.1%
3.03
US$34,045
11,239 -5.1% 3.03 US$34,045
2022-06-14 2022-06-13 S Sale
1,485 -1.6%
5.20
US$7,722
1,485 -1.6% 5.20 US$7,722
2022-06-14 2022-06-13 S Sale
66 -0.1%
5.35
US$353
66 -0.1% 5.35 US$353